DE4041351A1 - Testantigene zur intrakutanen anwendung in der medizinischen und veterinaermedizinischen diagnostik - Google Patents
Testantigene zur intrakutanen anwendung in der medizinischen und veterinaermedizinischen diagnostikInfo
- Publication number
- DE4041351A1 DE4041351A1 DE19904041351 DE4041351A DE4041351A1 DE 4041351 A1 DE4041351 A1 DE 4041351A1 DE 19904041351 DE19904041351 DE 19904041351 DE 4041351 A DE4041351 A DE 4041351A DE 4041351 A1 DE4041351 A1 DE 4041351A1
- Authority
- DE
- Germany
- Prior art keywords
- diagnosis
- listeriosis
- legionella
- legionellosis
- test antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000427 antigen Substances 0.000 title claims abstract description 17
- 102000036639 antigens Human genes 0.000 title claims abstract description 17
- 108091007433 antigens Proteins 0.000 title claims abstract description 17
- 238000012360 testing method Methods 0.000 title claims abstract description 15
- 206010024641 Listeriosis Diseases 0.000 title claims abstract description 9
- 238000003745 diagnosis Methods 0.000 title claims abstract description 9
- 208000007764 Legionnaires' Disease Diseases 0.000 title claims abstract description 8
- 241000589248 Legionella Species 0.000 title claims abstract description 7
- 241000186781 Listeria Species 0.000 title claims abstract description 5
- 210000003850 cellular structure Anatomy 0.000 title claims abstract 3
- 241000206605 Brochothrix Species 0.000 title claims description 3
- 208000004023 Legionellosis Diseases 0.000 title abstract description 6
- 230000003111 delayed effect Effects 0.000 claims abstract description 3
- 208000035473 Communicable disease Diseases 0.000 claims description 9
- 230000028993 immune response Effects 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims description 2
- 230000001419 dependent effect Effects 0.000 claims 1
- 241000894006 Bacteria Species 0.000 abstract description 2
- 102000004190 Enzymes Human genes 0.000 abstract description 2
- 108090000790 Enzymes Proteins 0.000 abstract description 2
- 230000004520 agglutination Effects 0.000 abstract description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 2
- 238000003018 immunoassay Methods 0.000 abstract description 2
- 238000010166 immunofluorescence Methods 0.000 abstract description 2
- 238000000034 method Methods 0.000 abstract description 2
- 201000010099 disease Diseases 0.000 abstract 1
- 230000008105 immune reaction Effects 0.000 abstract 1
- 230000024932 T cell mediated immunity Effects 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 238000001514 detection method Methods 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 206010014096 Echinococciasis Diseases 0.000 description 1
- 208000009366 Echinococcosis Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 241000589242 Legionella pneumophila Species 0.000 description 1
- 208000004554 Leishmaniasis Diseases 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 241000186779 Listeria monocytogenes Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 201000005485 Toxoplasmosis Diseases 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000012678 infectious agent Substances 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 238000003307 slaughter Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 229960001005 tuberculin Drugs 0.000 description 1
- 229940077094 tuberculosis diagnostics agent Drugs 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
- A61K49/0006—Skin tests, e.g. intradermal testing, test strips, delayed hypersensitivity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Endocrinology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Genetics & Genomics (AREA)
- Pathology (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19904041351 DE4041351A1 (de) | 1990-12-21 | 1990-12-21 | Testantigene zur intrakutanen anwendung in der medizinischen und veterinaermedizinischen diagnostik |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19904041351 DE4041351A1 (de) | 1990-12-21 | 1990-12-21 | Testantigene zur intrakutanen anwendung in der medizinischen und veterinaermedizinischen diagnostik |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE4041351A1 true DE4041351A1 (de) | 1992-07-02 |
| DE4041351C2 DE4041351C2 (enrdf_load_stackoverflow) | 1993-04-29 |
Family
ID=6421144
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19904041351 Granted DE4041351A1 (de) | 1990-12-21 | 1990-12-21 | Testantigene zur intrakutanen anwendung in der medizinischen und veterinaermedizinischen diagnostik |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE4041351A1 (enrdf_load_stackoverflow) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998022147A1 (en) * | 1996-11-22 | 1998-05-28 | Peridoc Ab | Testkit and method |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0165658A2 (en) * | 1984-06-20 | 1985-12-27 | Board Of Regents, The University Of Texas System | Methods and compositions for detection of legionnaires disease |
| WO1987005609A1 (en) * | 1986-03-12 | 1987-09-24 | University Of Tennessee Research Corporation | Monoclonal antibodies to legionella |
| WO1987006446A1 (en) * | 1986-04-25 | 1987-11-05 | Vascular Technology, Inc. | Method and apparatus for myocardial ischemia diagnosis |
| EP0254384A2 (en) * | 1986-03-27 | 1988-01-27 | Cetus Corporation | Direct and simultaneous assays for antigens in clinical specimens by monoclonal antibody immunoblot, antibodies for use therein and corresponding hybridomas |
-
1990
- 1990-12-21 DE DE19904041351 patent/DE4041351A1/de active Granted
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0165658A2 (en) * | 1984-06-20 | 1985-12-27 | Board Of Regents, The University Of Texas System | Methods and compositions for detection of legionnaires disease |
| WO1987005609A1 (en) * | 1986-03-12 | 1987-09-24 | University Of Tennessee Research Corporation | Monoclonal antibodies to legionella |
| EP0254384A2 (en) * | 1986-03-27 | 1988-01-27 | Cetus Corporation | Direct and simultaneous assays for antigens in clinical specimens by monoclonal antibody immunoblot, antibodies for use therein and corresponding hybridomas |
| WO1987006446A1 (en) * | 1986-04-25 | 1987-11-05 | Vascular Technology, Inc. | Method and apparatus for myocardial ischemia diagnosis |
Non-Patent Citations (2)
| Title |
|---|
| COLLINS, F.M., Campbell, S.G.: Veterinary Immunology and Immunopathology 3(1982), 5-66 * |
| HAHN, H., Kaufmann, H.E.: Review of Infections Diseases 3 (1981), 1221-1250 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998022147A1 (en) * | 1996-11-22 | 1998-05-28 | Peridoc Ab | Testkit and method |
| AU721997B2 (en) * | 1996-11-22 | 2000-07-20 | Peridoc Ab | Testkit and method |
| US6340455B1 (en) | 1996-11-22 | 2002-01-22 | Peridoc Ab | Testkit and method |
Also Published As
| Publication number | Publication date |
|---|---|
| DE4041351C2 (enrdf_load_stackoverflow) | 1993-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE1816712A1 (de) | Reaktive Teilchen fuer biologische Untersuchungen und Verfahren zu ihrer Herstellung | |
| DE69230918T2 (de) | Verfahren für die bestimmung von antikörpern in seronegativen personen | |
| DE69030480T2 (de) | Verfahren und Vorrichtung zum Nachweis sensibilisierter Leukozyten | |
| DE69633233T2 (de) | Multivalenter impstoff gegen bovines coronavirus und methode zur behandlung einer infektion mit bovinem coronavirus | |
| DE4041351C2 (enrdf_load_stackoverflow) | ||
| DE60218321T2 (de) | Nachweis des virus der viralen rinderdiarrhoe in gewebsproben | |
| DE2850950C3 (de) | Verwendung von nativem oder thermisch modifiziertem Cytochrom c als Stabilisator für ein immunochemisches Meßreagens, immunochemisches Meßreagens sowie Pufferlösung zur Probenverdünnung bei immunchemischen Meßverfahren | |
| DE2521460C2 (de) | Verfahren zum Nachweis von Antikörpern gegen Brucella canis und Antigenreagens | |
| CH646259A5 (de) | Diagnostisches mittel zur bestimmung eines antigens. | |
| Webster et al. | The mouse inoculation test in rabies diagnosis: early diagnosis in mice during the incubation period | |
| DE9017311U1 (de) | Testantigene zur intrakutanen Anwendung in der medizinischen und veterinärmedizinischen Diagnostik | |
| EP0267356B1 (de) | Verfahren und Testelement zum Auffinden von Zelläsionen | |
| Müller | Serologische Diagnostik der Mykosen | |
| DE4232073C2 (de) | Verfahren zur immunchemischen Quantifizierung von inaktivierten, immunreaktiven Antigenen | |
| DE1598928A1 (de) | Verfahren zum Nachweis der infektioesen Mononukleose und Nachweisreagenz | |
| EP2291658B1 (de) | Durchflusszytometrisches verfahren zur bestimmung von gesamtleukozytenzahl und trombozytenzahl sowie zur leukozytendifferenzierung in blutproben von vögeln | |
| CH666285A5 (de) | Verfahren zur bestimmung von interferon epsilon in einer probe. | |
| DE4112999C2 (de) | Verfahren und Nachweismittel zum Nachweis einer Infektion mit dem Epstein-Barr Virus | |
| EP2288920B1 (de) | Verfahren zur bestimmung von trichinella-infektionen | |
| DE69915437T2 (de) | Plasmasammlungen von mehr als 200 gesunden Patienten und davon abgeleiteter Kalibrierstandard | |
| DE2221927A1 (de) | Diagnostikum,Verfahren zu seiner Herstellung und diagnostisches Verfahren | |
| DE2560402C2 (de) | Verfahren zur Herstellung von zur Therapie von Hepatitis A geeignetem, menschlichem Immunserumglobulin | |
| DE1617344A1 (de) | Verfahren zur Herstellung einer Tetanus-Vaccine | |
| DE2626350C2 (de) | Impfstoff | |
| WO2022043129A1 (de) | Verfahren zur bestimmung der avidität von gegen coronavirus gerichteten antikörpern sowie hierzu geeignete testkits |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| OP8 | Request for examination as to paragraph 44 patent law | ||
| D2 | Grant after examination | ||
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |